Immunoassay Instruments MarketSize and Trends

A wide variety to address health problems drives the immunoassay instruments market

According to the Disease Prevention and Health Promotion estimates in 2017, the immunoassay techniques have prevented up to 14 million lives with early diagnosis, reducing the healthcare costs by $9.9 billion. The adoption of automated techniques to test various substances including antibiotic, anticonvulsant or cardiac glycoside drug concentration determination, cancer markers, endocrine hormone testing drives the market. Rising prevalence of infectious diseases with early diagnosis, prevention, and treatment is the main factor boosting the demand for compact consumable products and instruments in the healthcare sector. The launch of various FDA approved innovative products is expected to fuel the commercialization of immunoassay instruments significantly in the forecast period. For instance, the launch of fluorescence scanning portable instrument ichroma II and enzyme-linked immunosorbant assay (ELISA) test cartridge by iStat cardiac Troponin I.

Improved workflow owing to ease and comprehensive technology are the prominent factors estimated to boost the automated immunoassay instrument market

The global immunoassay instruments market is segmented on the basis of product, application, application, end user and geography.

On the basis of product, the global immunoassay instruments market is segmented into:

Enzyme-linked immunoassay
Radioimmunoassay
Chemiluminescence immunoassay
Immunofluorescence analyzers

On the basis of applications, the global immunoassay instruments market is segmented into:

Endocrinology
Cardiology
Oncology
Autoimmune and infectious disease testing
Others

On the basis of end user, the global immunoassay instruments market is segmented into:

Clinical Laboratories
Hospitals
Others

Market Trends

The use of analyzers and devices for biochemical tests in hospitals and clinical settings is increasing. The rise in innovative product launches and high sensitivity instruments continues to drive market trends.

The launch of automated chemiluminescence immunoassay instrument by Abbott to rise the demand of immunoassay instruments